Related Experiment Videos
Autosomal dominant polycystic kidney disease
1Department of Medicine, University of Chicago, IL 60637.
Journal of the American Society of Nephrology : JASN
|February 1, 1993
Summary
Autosomal dominant polycystic kidney disease (ADPKD) affects millions, causing kidney failure and other complications. Early genetic screening is possible, but patient education and counseling are crucial for timely detection and treatment.
Area of Science:
- Nephrology
- Genetics
- Molecular Biology
Background:
- Autosomal dominant polycystic kidney disease (ADPKD) is a significant cause of end-stage renal disease (ESRD), affecting 500,000 individuals in the US.
- ADPKD presents with renal complications like infections, pain, and kidney stones, alongside cardiovascular (aneurysms, hypertension) and gastrointestinal (hepatic cysts) manifestations.
Observation:
- The precise cellular defect causing ADPKD remains elusive, though abnormalities in cell proliferation, tubular basement membrane, and fluid secretion are implicated.
- Progressive interstitial fibrosis and renal function decline factors are not fully understood, but blood pressure control is a key therapeutic strategy.
Findings:
- Genetic linkage studies have localized the ADPKD gene to chromosome 16 in 90% of families, enabling early genetic screening for asymptomatic relatives.
- Diagnosis can impact employment and insurance, leading some family members to forgo screening.
Implications:
- Physician counseling is essential for individuals considering ADPKD screening due to social and economic implications.
- Improved patient education is vital for early detection, genetic counseling, and managing ADPKD complications effectively.